微生物群,微生物代谢物和干扰因子之间的交叉通话在炎症性肠道疾病中的肠道
Vi To Diep Vu1,2,3,4, Ramsha Mahmood1,2,3,4, Heather K Armstrong1,2,3,4,5,6
1Department of Immunology, University of Manitoba, 429 Apotex Centre, Winnipeg, MB, R3E 0T5Canada.
Journal of the Canadian Association of Gastroenterology
|February 5, 2024
概括
炎症性肠病 (IBD) 研究探讨了肠道微生物如何影响肠道健康至关重要的干扰素 (IFN). 了解这种联系可能会导致新的IBD疗法.
科学领域:
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
- 微生物学 微生物学
背景情况:
- 全球炎症性肠道疾病 (IBD) 的流行率不断上升,需要先进的治疗策略.
- 目前的IBD治疗方法通常集中在单一的免疫点上,但组合疗法显示出有前途.
- 干扰素 (IFN) 是粘膜免疫的关键细胞因子,在肠道平衡和炎症中具有I,II和III型家族的独特作用.
研究的目的:
- 在IBD的背景下,审查当前对肠道微生物群如何影响干扰素信号的理解.
- 探索各种IFN家族在调节肠道平衡和炎症中的不同作用.
- 阐明微生物代谢物,IFN和IBD病原体之间的相互作用.
主要方法:
- 文献综述综合了有关IBD,肠道微生物群和干扰素的现有研究.
- 对研究微生物对IFN通路的影响的研究分析.
- 检查动物模型和IBD人类患者的数据.
主要成果:
- 肠道微生物群及其代谢物被证明会影响IFN水平和反应.
- 不同的IFN家族在维持肠道平衡和调解炎症方面表现出不同的功能.
- 这些相互作用对IBD发展和进展的确切影响仍在被澄清.
结论:
- 对微生物群-IFN轴的全面理解对于开发有效的IBD治疗是至关重要的.
- 针对这一轴可以提供超越传统单蛋白抑制的新治疗途径.
- 需要进一步的研究才能完全解开复杂的相互作用,以改善患者的治疗结果.
相关概念视频
01:17Irritable Bowel Syndrome I: Introduction
276
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
276
01:30Inflammatory Bowel Disease II: Crohn's Disease
244
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
244
01:29Inflammatory Bowel Disease IV: Pharmacological Management
127
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
127
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
334
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
334
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
186
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
186
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
137
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
137